Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
224 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (4)
  • (-) Closed (4)

Medical Condition

  • Show all (997)
  • Addiction (12)
  • Allergy, Asthma, & Immunology (12)
  • All of Us Research Program - NIH (1)
  • Autoimmune Disorders (25)
  • Blood Disorders (18)
  • Bone & Muscle (8)
  • Cancer (93)
    • Brain Cancer (3)
    • Breast Cancer (11)
    • Gastrointestinal (2)
    • Gynecologic Cancer (29)
    • Kidney Cancer (1)
    • Leukemia (6)
    • Liver Cancer (1)
    • Lung Cancer (4)
    • Lymphoma (10)
    • Multiple Myeloma (2)
    • Pancreatic Cancer (1)
    • (-) Prostate Cancer (3)
    • Sarcoma (2)
    • Skin Cancer (2)
    • Solid Tumors (4)
  • Child Development (4)
  • COVID-19 (Coronavirus) (28)
  • Critical Illness (1)
  • Diabetes (14)
  • Ear, Nose and Throat (5)
  • Endocrine & Metabolic Disease (10)
    • Cushing's Disease (3)
    • (-) Growth Hormone Deficiency (1)
  • Eye (7)
  • Gastrointestinal and Digestive Diseases (23)
  • Hair and Skin Disorders (2)
  • Headaches (5)
  • Healthy Volunteers (143)
  • Heart Disease (109)
  • Infectious Disease (38)
  • Insomnia (2)
  • Kidney Disease (12)
  • Liver Disease (40)
  • Lung Disease (29)
  • Meniere's Disease (1)
  • Neurological Disorders (95)
  • Nutrition (3)
  • Obesity (1)
  • Obstetrics & Gynecology (46)
  • Pain Management (1)
  • Pediatrics (84)
  • Psychiatric Disorders (61)
  • Rehabilitation (7)
  • Stroke (5)
  • Surgery (7)
  • Transplant (33)
  • Urology (3)
  • Vascular Conditions (9)
Displaying 1 - 4 of 4

Study of BMS-986218 Alone or in Combination with Nivolumab for Male Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Condition: Cancer / Prostate Cancer
Investigator: Karie D. Runcie, MD
Status: Closed
The purpose of this study is to assess the effectiveness and safety of combining an investigational drug called BMS-986218 (also known as Anti-CTLA4-NF monoclonal antibody), or BMS-986218 plus nivolumab, with standard of care docetaxel (chemotherapy), in men who have metastatic castration-resistant prostate cancer (mCRPC) that progressed after a second-…
Read More

Diffuse Optical Tomography in Prostate Cancer Detection and Risk Stratification - A Pilot Study

Condition: Cancer / Prostate Cancer
Investigator: Emerson Lim, MD
Status: Closed
You are being asked to join this study because you have either been diagnosed with prostate cancer and will be having surgery to remove your prostate or you will be having a prostate biopsy to look for prostate cancer. This study is looking to see if a new imaging device, diffuse optical tomography (DOT), can detect prostate cancer. We will also see if DOT…
Read More

A study for adults with growth hormone deficiency using study drug NNC0195-0092

Condition: Endocrine & Metabolic Disease / Growth Hormone Deficiency
Investigator: Pamela Freda, MD
Status: Closed
The purpose of this study is to investigate how well weekly injections of the growth hormone drug NNC0195-0092 works in adults with growth hormone deficiency. Growth hormone deficiency is a disorder that involves the pituitary gland (a small gland located at the base of the brain). The gland produces growth hormone and other hormones (chemical messengers of…
Read More

A study for patients with Metastatic Castration-resistant Prostate Cancer (mCRPC) using study drug JNJ-56021927

Condition: Cancer / Prostate Cancer
Investigator: Edward Gelmann, MD
Status: Closed
The purpose of this study is to compare the clinical benefit (i.e., does it help to improve or slow down the cancer) of adding study drug JNJ-56021927 to combined treatment of abiraterone acetate plus prednisone to treat patients with metastatic Castration-resistant Prostate Cancer (mCRPC). This study will also evaluate the possible side effects of study…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science